The OECD has undertaken a statistical analysis of the determinants of health and the relative efficiency of the health care systems of OECD member countries.

A new law specifying provisionsfor all health insurance policies is unprecedented interference by the federal government intoprivate health insuranceand will have a series of ill effects.

Thisbook shows that it is time to rethink conventional wisdom regarding consumption of pharmaceuticals.

This volume contradicts the commonly-held belief that, among rich countries, the marginal return from pharmaceutical consumption is negligible.

This book analyzes the changing nature of competition in this market, with a specific focus on competition among physicians, hospitals, and insurance companies.